Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Skip to content
DOWNLOAD LIBRARY

DOWNLOAD LIBRARY

Date Document Type

Compensation Committee Charter

Nominating and Corporate Governance Committee Charter

Audit Committee Charter

View Presentation

View Presentation

View Prepared Remarks

Form 8-K

View Presentation

View Transcript

View Presentation

View Presentation

Veracyte Investor Presentation, November 2017

Financial Presentation

William Blair 35th Annual Growth Stock Conference Presentation

Veracyte Investor Day 2014 Presentation